Clinical Trial: The Purpose of This Study is to Evaluate the Efficacy and the Safety of MDI-1228 Mesylate Gel Compared With Standard of Care Alone in Patients With Chronic Diabetic Foot Ulcers

U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06852976) titled 'The Purpose of This Study is to Evaluate the Efficacy and the Safety of MDI-1228 Mesylate Gel Compared With Standard of Care Alone in Patients With Chronic Diabetic Foot Ulcers' on Feb. 10.

Brief Summary: The study will evaluate the treatment effect of MDI-1228-mesylate Gel compared with standard of care alone for the complete healing rate at the end of 12 weeks in participants with diabetic foot ulcers (targeted ulcer). In addition, the proportion of subjects whose target ulcer area is reduced by 50% after 12 weeks of treatment.

Study Start Date: Feb., 2025

Study Type: INTERVENTIONAL

Condition: Diabetic Foot Ulcer

Intervention...